Cargando…
Ceftobripole: Experience in staphylococcal bacteremia
Ceftobiprole is a new cephalosporin with an extended spectrum activity against the majority of microorganisms isolated in bacteremia including methicillin-susceptible (MSSA) and -resistant S. aureus (MRSA). This antibiotic has demonstrated a potent activity against MRSA in animal models of endocardi...
Autores principales: | Soriano, Alex, Morata, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Quimioterapia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755346/ https://www.ncbi.nlm.nih.gov/pubmed/31364338 |
Ejemplares similares
-
Possible clinical indications of ceftobiprole
por: Barberán, José
Publicado: (2019) -
Ceftobiprole: pharmacokinetics and PK/PD profile
por: Azanza Perea, José Ramón, et al.
Publicado: (2019) -
Introduction
por: Llinares, Pedro, et al.
Publicado: (2019) -
Safety and tolerability of ceftobiprole
por: Grau, Santiago
Publicado: (2019) -
Ceftobiprole for the treatment of pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)